News
Since acquiring agri-giant Monsanto in 2018, pharmaceutical company Bayer has sought to protect itself from legal liabilities ...
4d
Pharmaceutical Technology on MSNBayer’s Eylea market grip set to slip as Alvotech biosimilar closes inAn EMA committee has recommended approval of Alvotech’s AVT06, a biosimilar to Bayer’s blockbuster ophthalmology drug Eylea.
A group of EU and US scientists claiming that low doses of the weed killer glyphosate "cause multiple types of cancer in rats.
Bayer's Louisiana glyphosate plant is back online, ... Bayer says as demand for glyphosate products remains high, the company is working to provide access to them for farmers.
German drugmaker Bayer (BAYN: DE) has renewed its partnership with China’s Tsinghua University for another three years, ...
German agribusiness giant Bayer in April announced it filed a petition for writ of certiorari with the U.S. Supreme Court, ...
Standing by the side of Highway 63 with the Missouri state Capitol on the horizon, there’s a billboard that says, “Stand Up for Glyphosate.” Glyphosate is the key ingredient of Roundup, the flagship ...
In combination with Roche’s PD-L1 blocker Tecentriq, zanzalintinib bested Bayer’s Stivarga. Exelixis is positioning the drug ...
Awards Program Honors Standout AI Companies & SolutionsLOS ANGELES, June 25, 2025 (GLOBE NEWSWIRE) -- AI Breakthrough, a ...
Bayer has stepped up the digital capabilities of its radiology business with the launch of artificial intelligence-based apps for X-ray, MRI and CT imaging. The cloud-hosted platform – called ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results